Boston University
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1839-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.bu.edu
Clinical Trials
266
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (216 trials with phase data)• Click on a phase to view related trials
Postural Perturbations Tracing to the Stomatognathic System
- Conditions
- Posture
- First Posted Date
- 2025-05-16
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Boston University
- Target Recruit Count
- 40
- Registration Number
- NCT06974591
- Locations
- 🇺🇸
Goldman School of Dental Medicine, Boston University, Boston, Massachusetts, United States
RISE Versus Advocacy-based Enhanced Care as Usual for Patients Experiencing IPV
- Conditions
- Intimate Partner Violence (IPV)
- First Posted Date
- 2025-04-02
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Boston University
- Target Recruit Count
- 172
- Registration Number
- NCT06906302
- Locations
- 🇺🇸
VA Boston Healthcare System, Boston, Massachusetts, United States
🇺🇸VA Minneapolis Healthcare System, Minneapolis, Minnesota, United States
🇺🇸VA Philadelphia Healthcare System, Philadelphia, Pennsylvania, United States
Advanced HIV Disease During the First Six Months on Antiretroviral Therapy in Zambia
- Conditions
- Advanced HIV Disease
- First Posted Date
- 2025-04-01
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- Boston University
- Target Recruit Count
- 11800
- Registration Number
- NCT06904456
- Locations
- 🇿🇲
CHAI-Zambia, Lusaka, Zambia
The DIAGNOSE CTE Research Project-II
- Conditions
- Chronic Traumatic Encephalopathy (CTE)Alzheimer DiseaseAlzheimer Disease and Related Dementias (ADRD)Brain Injuries, Traumatic
- First Posted Date
- 2025-03-06
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- Boston University
- Target Recruit Count
- 350
- Registration Number
- NCT06860828
- Locations
- 🇺🇸
Banner Alzheimer's Institute (BAI) and Mayo Clinic Arizona, Phoenix, Arizona, United States
🇺🇸University of California, San Francisco (UCSF) Alzheimer Disease Research Center (ADRC), San Francisco, California, United States
🇺🇸1Florida ADRC, University of Florida, Gainesville, Florida, United States
Evaluation of a Trauma-Informed Partner Violence Intervention Program
- Conditions
- Domestic ViolencePost Traumatic Stress Disorder
- First Posted Date
- 2025-01-31
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- Boston University
- Target Recruit Count
- 800
- Registration Number
- NCT06803043
- Locations
- 🇺🇸
CABU School of Medicine, Psychiatry, Boston, Massachusetts, United States
🇺🇸Rhode Island Hospital, Providence, Rhode Island, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 53
- Next
News
Novel Royalty-Based Investment Fund Proposes New Model for ALS Drug Development
Researchers from MIT, Massachusetts General Hospital, and Boston University propose a novel "Fund of Adaptive Royalties" (FAR) that finances half the cost of adaptive platform trials in exchange for future drug royalties.
Alzheimer's Drug Discovery Foundation Partners with Siemens Healthineers to License SpeechDx Dataset for Speech-Based Biomarker Development
The Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator has partnered with Siemens Healthineers to license the SpeechDx dataset, marking the first commercial partnership for this gold-standard speech and clinical data collection.
American Heart Association Awards $1M to Study GLP-1 Medications' Impact on Cardiovascular Risk
The American Heart Association has funded seven research projects with $1 million to identify which patients with obesity and cardiovascular disease benefit most from GLP-1/GIP medications.